Literature DB >> 21309669

Risk factors and diagnosis of flat adenomas of the colon.

Joseph C Anderson1.   

Abstract

In addition to histology, size and location, a morphologic description can be ascribed to polyps and adenomas. Traditionally, adenomas have been described as sessile and pedunculated, but it is now accepted that they can also present as flat or even depressed. Although first recognized in 1985, flat adenomas have become more common in Western published literature and in endoscopic reports. The Japanese Research Society Classification describes flat adenomas as lesions with a height that is less than one half of the diameter, while the Paris classification divides polyps into protruding and nonprotruding. The clinical significance of flat adenomas includes their potential malignancy, difficulty in detection and possible role in interval cancers. Serrated polyps represent a subset of polyps that have all the features that make flat lesions clinically important. Due to the relatively recent recognition of these lesions, as well as the technology required to detect them, the prevalence and malignant potential of these lesions in Western patients are still unknown. Finally, the best techniques and equipment for detecting flat polyps are also not established. In this article, we examine the issue of flat polyps and their significance in colorectal cancer screening with regard to prevalence, risk factors and methods for detecting flat polyps.

Entities:  

Mesh:

Year:  2011        PMID: 21309669     DOI: 10.1586/egh.10.86

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  3 in total

Review 1.  Endoscopy and polyps-diagnostic and therapeutic advances in management.

Authors:  Scott R Steele; Eric K Johnson; Bradley Champagne; Brad Davis; Sang Lee; David Rivadeneira; Howard Ross; Dana A Hayden; Justin A Maykel
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

2.  A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.

Authors:  Jason D Whitt; Nan Li; Heather N Tinsley; Xi Chen; Wei Zhang; Yonghe Li; Bernard D Gary; Adam B Keeton; Yaguang Xi; Ashraf H Abadi; William E Grizzle; Gary A Piazza
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-03

Review 3.  New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets.

Authors:  Pooneh Mokarram; Mohammed Albokashy; Maryam Zarghooni; Mohammad Amin Moosavi; Zahra Sepehri; Qi Min Chen; Andrzej Hudecki; Aliyeh Sargazi; Javad Alizadeh; Adel Rezaei Moghadam; Mohammad Hashemi; Hesam Movassagh; Thomas Klonisch; Ali Akbar Owji; Marek J Łos; Saeid Ghavami
Journal:  Autophagy       Date:  2017-02-23       Impact factor: 16.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.